Science · Open for opinions
Will the FDA or WHO issue an alert or formal review regarding pediatric fluoxetine by November 30, 2026?
Consider stances from health agencies following reanalysis of pediatric efficacy between 10/22 and 11/30. 85 opinions, 75% No
- Yes — 25%
- No — 75%
Deadline: November 30, 2026 at 11:59 PM UTC · 85 opinions
Resolution rules
Consider stances from health agencies following reanalysis of pediatric efficacy between 10/22 and 11/30.
Source: www.nature.com
Frequently asked questions about this event
How is this event resolved?
Janela de apuração: de 22/10/2026 (00:00, horário de Brasília) até 30/11/2026 (23:59). Fatos, anúncios ou eventos anteriores ao início da janela não contam. Resolve como 'Sim' se a FDA dos EUA ou a Organização Mundial da Saúde (OMS) publicar nota técnica, alerta de segurança ou atualização de diretriz sobre o uso de fluoxetina em crianças e adolescentes até 30/11/2026, conforme seus portais oficiais (fda.gov ou who.int). Caso contrário, resolve como 'Não'.
How are points scored?
Points depend on the share of votes your side had when you gave your opinion. Being right earns 100 minus that share. Being wrong costs that share.
Right now No has 75% of the votes: an opinion on it that turns out right earns about 25 points, a wrong one costs about 75.